We synthesized a variant, recombinant fibrinogen modeled after the heterozygous dysfibrinogen Vlissingen/Frankfurt IV, a deletion of two residues, ␥Asn-319 and ␥Asp-320, located within the high affinity calciumbinding pocket. Turbidity studies showed no evidence of fibrin polymerization, although size exclusion chromatography, transmission electron microscopy, and dynamic light scattering studies showed small aggregates. These aggregates did not resemble normal protofibrils nor did they clot. Fibrinopeptide A release was normal, whereas fibrinopeptide B release was delayed approximately 3-fold. Plasmin cleavage of this fibrinogen was not changed by the presence of calcium or Gly-Pro-ArgPro, indicating that both the calcium-binding site and the "a" polymerization site were non-functional. We conclude that the loss of normal polymerization was due to the lack of "A-a" interactions. Moreover, functions associated with the C-terminal end of the ␥ chain, such as platelet aggregation and factor XIII cross-linking, were also disrupted, suggesting that this deletion of two residues affected the overall structure of the C-terminal domain of the ␥ chain.Fibrinogen is a 340-kDa glycoprotein that consists of six polypeptides chains, (A␣, B, and ␥) 2 . The molecule is symmetric, consisting of two globular D nodules connected to a central E nodule by a coiled-coil region (1). The D nodule consists of a portion of the coiled-coil region and the C termini of both the B and ␥ chains, whereas the E nodule consists of the N termini of all six polypeptides. Thrombin cleaves the N termini of both the A␣ and the B chains, releasing fibrinopeptides A (FpA) 1 and B (FpB) and producing fibrin monomers that polymerize to form a fibrin clot. FpA is released first, exposing the polymerization site "A" that binds to the polymerization site "a" in the ␥ chain in the D domain of another molecule (2). This "A-a" interaction allows molecules to align into double-stranded, half-staggered protofibrils (3, 4). It is unclear by what molecular mechanism FpB release affects polymerization, although a commonly accepted model proposes that FpB is released from growing protofibrils, enhancing the assembly of protofibrils into fibers (5-7). Release of FpB exposes the "B" polymerization site that binds to the "b" site (2), which may be located in the B chain (8, 9) or the A␣ chain (10). In vivo, the result of fibrin polymerization is an intricate fibrous network that, along with plate-